Yale doctors weigh in on the first FDA-approved schizophrenia drug in nearly 30 years

Yale Daily News

Oct 7, 2024

On Sept. 26, for the first time in nearly 30 years, the U.S. Food and Drug Administration approved a new oral drug, Cobenfy, developed by Bristol Myers Squibb, to treat schizophren…